Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Indonesia will administer a possible coronavirus vaccine, developed by private Chinese biopharmaceutical firm Sinovac, to over 1,000 subjects starting in August. The trial brings hope of ending the COVID-19 pandemic in Indonesia and the rest of the world.

However, some have questioned the vaccine’s clinical certification and feel that Indonesians are simply the “guinea pigs” of an experiment.

Read related articles here and here.